Virtual Investor Co. (@InvestorVirtual) / X

Virtual Investor Co.

765 posts

Virtual Investor Co.

@InvestorVirtual

An online platform that offers public and private companies, across multiple industries the ability to stay active and engaged with the investment community.

virtualinvestorco.com

Joined May 2020

Following

2,424

Followers

Virtual Investor Co.
@InvestorVirtual
7h
Dare Biosciences participated in a Virtual Investor "What This Means" segment to discuss the upcoming launch of Flora Sync LF5™, its first consumer health product. Hear CEO Sabrina Martucci Johnson share what this milestone means: vimeo.com/1204320941/59b… $DARE #WomensHealth
155
Virtual Investor Co.
@InvestorVirtual
Jun 9
⏰ Starting Soon! $NVNO is about to begin its #VirtualInvestor Closing Bell event. Tune in for the latest updates and take part in the live Q&A. Join here 👇 bit.ly/4vmHrYU @enVVenoMedical #VenousDisease #DeepVenousInsufficiency #CVI #CVD
47
Virtual Investor Co.
@InvestorVirtual
Jun 9
In a #VirtualInvestor #KOLConnect segment, Dr. Ira Winer discusses the unmet need in ovarian cancer, the challenge of immunologically “cold” tumors and the potential of scalable, off-the-shelf engineered cell therapies. 🔗: vimeo.com/1199557462/89d… $ERNA
87
Virtual Investor Co.
@InvestorVirtual
Jun 9
🔔 Live Today at 4 PM ET! Join @enVVenoMedical live in their #VirtualInvestor Closing Bell segment for the latest corporate updates, key progress highlights, and a look at upcoming initiatives. Watch live here: bit.ly/4vmHrYU $NVNO #VenousDisease #CVI #CVD
25
Virtual Investor Co.
@InvestorVirtual
Jun 8
⏰ Happening Tomorrow at 4 PM ET Catch CEO Robert Berman live as he discusses the latest updates from $NVNO during a #VirtualInvestor Closing Bell session. Be sure to tune in! Don't miss it: bit.ly/4vmHrYU @enVVenoMedical #VenousDisease #DeepVenousInsufficiency #CVI
19
Virtual Investor Co.
@InvestorVirtual
Jun 8
In a #VirtualInvestor #WhatThisMeans segment, Steve O’Loughlin, CFO of CNS Pharmaceuticals, discusses the Company’s oversubscribed $22.5 million financing and the momentum behind its strategic transformation. 🔗: vimeo.com/1199387433/bcc… $CNSP #Oncology
552
Virtual Investor Co.
@InvestorVirtual
Jun 4
Dr. Toufic Kachaamy, Chief of Medicine at City of Hope Phoenix, joins a #WhatThisMeans segment to discuss the clinical significance of $AMIX’s data presented at the SSO Annual Meeting and its selection for a podium presentation. 🔗: vimeo.com/1198379906/a5e… #MedTech
1.5K
Virtual Investor Co.
@InvestorVirtual
Jun 4
In a #WhatThisMeans segment, Tom Equels, Dr. Charles Lapp and Dr. Christopher Nicodemus, examine current Ebola outbreak concerns, the unmet need surrounding the Bundibugyo strain, and Ampligen’s previously published antiviral research. 🔗: vimeo.com/1198375699/68d… $AIM #Ebola
1K
Virtual Investor Co.
@InvestorVirtual
Jun 4
In a #WhatThisMeans segment, Walter Klemp, CEO of $MBRX, discusses the enrollment of the 45th subject in Moleculin’s pivotal Phase 2B/3 MIRACLE trial evaluating AnnAraC for relapsed or refractory AML. 🔗Watch here:
471
Virtual Investor Co.
@InvestorVirtual
Jun 3
📅 Mark Your Calendar enVVeno Medical will take part in a #VirtualInvestor Closing Bell segment on June 9 at 4 PM ET. Tune in to hear key updates from CEO Robert Berman. Register Here: bit.ly/4vmHrYU $NVNO #VenousDisease #DeepVenousInsufficiency #CVI #CVD
138
Virtual Investor Co.
@InvestorVirtual
May 28
In a #VirtualInvestor “What This Means” segment, @AkariTX CEO Abizer Gaslightwala discusses the Company’s first ASCO abstract acceptance and preclinical KRAS synergy data supporting its differentiated ADC platform. Watch here: vimeo.com/1196309773/3a3… $AKTX #ASCO #Oncology
318
Virtual Investor Co.
@InvestorVirtual
May 20
In a #VirtualInvestor #KOLConnect segment, Dr. Elena Ratner discusses the unmet need in ovarian cancer, immunologically “cold” tumors, and Ernexa’s differentiated off-the-shelf cell therapy approach. 🔗vimeo.com/1193963843/b7a… $ERNA @ErnexaTx
838
Virtual Investor Co.
@InvestorVirtual
May 20
In a #VirtualInvestor #CEOConnect segment, Rami Levin highlights the Company’s recent strategic transformation progress, including its $22.5 million financing and pipeline development strategy focused on long-term shareholder value creation. 🔗: vimeo.com/1193965352/6cf… $CNSP
324